Skip to content

Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention

Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02962115
Enrollment
1000
Registered
2016-11-11
Start date
2016-11-30
Completion date
2017-03-31
Last updated
2022-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasms

Brief summary

This study evaluates the feasibility of a clinical informatics system-based approach to lung cancer screening. Patients of a large academic medical center who may qualify for lung cancer screening will be sent an electronic invitation to complete an online lung cancer screening decision aid.

Detailed description

The Center for Medicaid and Medicare Services (CMS) recently approved the use of low-dose chest CT scans for lung cancer screening in patients who meet specific criteria. However, many individuals who meet these criteria do not realize they qualify for screening. This study will determine the feasibility of using a clinical informatics approach to systematically identify potential candidates for LDCT screening, reach out to them via the patient portal, and use a web app to provide them with a personalized LDCT screening decision aid and facilitate the ordering of screening tests.

Interventions

BEHAVIORALDecision Aid Invitation

electronic invitation to complete web-based decision aid

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to 77 Years
Healthy volunteers
No

Inclusion criteria

* Has an active patient portal account * Scheduled to see a Wake Forest primary care provider within the next 4 weeks

Exclusion criteria

* Never smokers * Current or former history of lung cancer * Receipt of chest CT scan within last 12 months * Need for a language interpreter * Presence of disease predicting short life-expectancy

Design outcomes

Primary

MeasureTime frameDescription
Receipt of LDCT screening120 daysNumber of participants who received a low-dose chest CT

Secondary

MeasureTime frameDescription
Visit web decision aid120 daysNumber of participants who visited the study website
Complete web decision aid120 daysNumber of participants who complete the lung cancer screening eligibility items
Read portal invitation120 daysNumber of participants who read the portal invitation
Interest in LDCT screening120 daysNumber of participants who indicate they are interested in receiving LDCT
Appointment for LDCT visit120 daysNumber of participants who are scheduled for a lung cancer screening clinic visit or a LDCT exam
Eligible for LDCT120 daysNumber of participants who are confirmed eligible for LDCT by the study website

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026